Cargando…

LOX-1 in Ischemic Stroke

Detalles Bibliográficos
Autores principales:	Sawamura, Tatsuya, Fujita, Yoshiko, Horiuchi, Sayaka, Kakino, Akemi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Japan Atherosclerosis Society 2017
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5453681/ https://www.ncbi.nlm.nih.gov/pubmed/28442661 http://dx.doi.org/10.5551/jat.ED071

Ejemplares similares

The Discovery of LOX-1, its Ligands and Clinical Significance
por: Yoshimoto, Ryo, et al.
Publicado: (2011)

A Novel Cell-Free, Non-Fluorescent Method to Measure LOX-1-Binding Activity Corresponding to The Functional Activity of HDL
por: Kakino, Akemi, et al.
Publicado: (2019)

Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox
por: NISHIZUKA, Taichi, et al.
Publicado: (2011)

Deletion of LOX-1 Protects against Heart Failure Induced by Doxorubicin
por: Yokoyama, Chiharu, et al.
Publicado: (2016)

Erratum to “Procyanidins are potent inhibitors of LOX-1: a new player in the French Paradox”: [Proc. Jpn. Acad., Ser. B 87, No. 3, 104–113]
por: NISHIZUKA, Taichi, et al.
Publicado: (2011)

High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study
por: Yokota, Chiaki, et al.
Publicado: (2016)

Detection of a High Ratio of Soluble to Membrane‐Bound LOX‐1 in Aspirated Coronary Thrombi From Patients With ST‐Segment–Elevation Myocardial Infarction
por: Lee, An‐Sheng, et al.
Publicado: (2020)

Adiponectin forms a complex with atherogenic LDL and inhibits its downstream effects
por: Kakino, Akemi, et al.
Publicado: (2020)

sLOX-1: A Molecule for Evaluating the Prognosis of Recurrent Ischemic Stroke
por: Zheng, Yangmin, et al.
Publicado: (2021)

Critical role of oxidized LDL receptor-1 in intravascular thrombosis in a severe influenza mouse model
por: Ohno, Marumi, et al.
Publicado: (2021)

LOX-1 boosts immunity
por: Oh, SangKon, et al.
Publicado: (2015)

LOX-1 Plays an Important Role in Ischemia-Induced Angiogenesis of Limbs
por: Shiraki, Takeru, et al.
Publicado: (2014)

Role of sLOX‐1 in intracranial artery stenosis and in predicting long‐term prognosis of acute ischemic stroke
por: Li, Xian‐Mei, et al.
Publicado: (2017)

Aging and ischemic stroke
por: Yousufuddin, Mohammed, et al.
Publicado: (2019)

Identification of a novel enzyme from E. pacifica that acts as an eicosapentaenoic 8R-LOX and docosahexaenoic 10R-LOX
por: Yuki, Sayaka, et al.
Publicado: (2020)

Ischemic stroke – the challenge continues
por: Demarin, Vida, et al.
Publicado: (2016)

Be mindful of potential pitfalls when using the Cre-LoxP system in cancer research
por: Czarnota, Piotr, et al.
Publicado: (2023)

Association of the LOX-1 rs1050283 Polymorphism with Risk for Atherosclerotic Cerebral Infarction and its Effect on sLOX-1 and LOX-1 Expression in a Chinese Population
por: Guo, Xin, et al.
Publicado: (2017)

Improved scFv Anti-LOX-1 Binding Activity by Fusion with LOX-1-Binding Peptides
por: Hu, Wei, et al.
Publicado: (2017)

Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 Receptor
por: Chu, Chih-Sheng, et al.
Publicado: (2013)

LOX-1, OxLDL, and Atherosclerosis
por: Pirillo, Angela, et al.
Publicado: (2013)

LOX-1 and Angiotensin Receptors, and Their Interplay
por: Wang, Xianwei, et al.
Publicado: (2011)

LOX-1 and cancer: an indissoluble liaison
por: Murdocca, M., et al.
Publicado: (2021)

Ischemic stroke and heart failure: facts and numbers
por: Scherbakov, Nadja, et al.
Publicado: (2015)

Are Patients Getting Their Aspirin's Worth in Ischemic Stroke?
por: Schmaier, Alec A., et al.
Publicado: (2018)

Potential New Therapeutic Intervention for Ischemic Stroke
por: Wu, Jang-Yen, et al.
Publicado: (2021)

The omentum in the surgical treatment of recurrent ischemic stroke
por: Goldsmith, Harry S.
Publicado: (2021)

Introduction to the Special Issue on Ischemic Stroke in Children
por: Sarecka-Hujar, Beata, et al.
Publicado: (2022)

Cellular and Molecular Targets in Acute Ischemic Stroke
por: Kraft, Peter, et al.
Publicado: (2022)

New Advances in Diagnostic Radiology for Ischemic Stroke
por: Broocks, Gabriel, et al.
Publicado: (2023)

Advance of Thrombolysis and Thrombectomy in Acute Ischemic Stroke
por: Nam, Hyo Suk, et al.
Publicado: (2023)

Dimethyl fumarate for ischemic stroke
por: Kunze, Reiner
Publicado: (2017)

Replacing the wild type loxP site in BACs from the public domain with lox66 using a lox66 transposon
por: Chatterjee, Pradeep K, et al.
Publicado: (2010)

“Affimer” synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1/2 activation
por: Roper, Barnaby W.R., et al.
Publicado: (2023)

Abnormal Blood Coagulation and Kidney Damage in Aged Hamsters Infected with Severe Acute Respiratory Syndrome Coronavirus 2
por: Ohno, Marumi, et al.
Publicado: (2021)

Pro-oncogenic action of LOX-1 and its splice variant LOX-1Δ4 in breast cancer phenotypes
por: Pucci, Sabina, et al.
Publicado: (2019)

Cerebral Microbleeds: Treatment Conundrum in Acute Ischemic Stroke
por: Ramanathan, Ramnath Santosh
Publicado: (2017)

Oxidized LDL and LOX-1 in Experimental Sepsis
por: Al-Banna, Nadia, et al.
Publicado: (2013)

LOX-1: Implications in atherosclerosis and myocardial ischemia
por: Sharma, Tanya, et al.
Publicado: (2022)

Correlation of sLOX-1 Levels and MR Characteristics of Culprit Plaques in Intracranial Arteries with Stroke Recurrence
por: Ren, Kaixuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_m3268b8u38rskm8h9jsavf0kfs